Cargando…

SARS-CoV-2 variants and ending the COVID-19 pandemic

Detalles Bibliográficos
Autores principales:	Fontanet, Arnaud, Autran, Brigitte, Lina, Bruno, Kieny, Marie Paule, Karim, Salim S Abdool, Sridhar, Devi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906631/ https://www.ncbi.nlm.nih.gov/pubmed/33581803 http://dx.doi.org/10.1016/S0140-6736(21)00370-6

Ejemplares similares

Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic
por: Karim, Salim S Abdool, et al.
Publicado: (2021)

Beta SARS-CoV-2 variant and BNT162b2 vaccine effectiveness in long-term care facilities in France
por: Lefèvre, Benjamin, et al.
Publicado: (2021)

One Health approach at the heart of the French Committee for monitoring and anticipating health risks
por: Lefrançois, Thierry, et al.
Publicado: (2023)

The WHO we want
por: Nay, Olivier, et al.
Publicado: (2020)

Future scenarios for the COVID-19 pandemic
por: Skegg, David, et al.
Publicado: (2021)

Vaccines and SARS-CoV-2 variants: the urgent need for a correlate of protection
por: Karim, Salim S Abdool
Publicado: (2021)

The pandemic legacy of antimicrobial resistance in the USA
por: Patel, Jay, et al.
Publicado: (2022)

SARS-CoV-2 elimination, not mitigation, creates best outcomes for health, the economy, and civil liberties
por: Oliu-Barton, Miquel, et al.
Publicado: (2021)

New SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine Implications
por: Abdool Karim, Salim S., et al.
Publicado: (2021)

Decoding the next SARS-CoV-2 variant
por: Nel, Jeremy, et al.
Publicado: (2022)

COVID-19 herd immunity: where are we?
por: Fontanet, Arnaud, et al.
Publicado: (2020)

The SARS-CoV2 pandemic and routine immunisation
por: Kang, Gagandeep
Publicado: (2022)

Will SARS-CoV-2 variants of concern affect the promise of vaccines?
por: Gupta, Ravindra K.
Publicado: (2021)

SARS-CoV-2 variants and considerations of inferring causality on disease severity
por: Cevik, Muge, et al.
Publicado: (2021)

Managing waning vaccine protection against SARS-CoV-2 variants
por: Leung, Kathy, et al.
Publicado: (2022)

Recalling ancestral SARS-CoV-2 variants: is it an original sin with benefits?
por: Hoehl, Sebastian, et al.
Publicado: (2023)

SARS-CoV-2 delta variant: a persistent threat to the effectiveness of vaccines
por: Thiruvengadam, Ramachandran, et al.
Publicado: (2022)

Travel measures in the SARS-CoV-2 variant era need clear objectives
por: Kucharski, Adam J, et al.
Publicado: (2022)

Antigenic evolution will lead to new SARS-CoV-2 variants with unpredictable severity
por: Markov, Peter V., et al.
Publicado: (2022)

Vaccination and protective immunity to SARS-CoV-2 omicron variants in people with immunodeficiencies
por: Nadesalingam, Angalee, et al.
Publicado: (2023)

Endemic SARS-CoV-2 will maintain post-pandemic immunity
por: Veldhoen, Marc, et al.
Publicado: (2021)

Affordable SARS-CoV-2 protein vaccines for the pandemic endgame
por: Triccas, James A., et al.
Publicado: (2022)

What is the vaccine effect on reducing transmission in the context of the SARS-CoV-2 delta variant?
por: Wilder-Smith, Annelies
Publicado: (2022)

Importance of epidemiological factors in the evaluation of transmissibility and clinical severity of SARS-CoV-2 variants
por: Lechien, Jérôme R, et al.
Publicado: (2022)

Understanding how fast SARS-CoV-2 variants transmit from household studies
por: Yang, Yang, et al.
Publicado: (2022)

Neutralizing antibodies and their cocktails against SARS-CoV-2 Omicron and other circulating variants
por: Yang, Yang, et al.
Publicado: (2022)

SARS-CoV-2 variants offer a second chance to fix vaccine inequities
por: Hotez, Peter J.
Publicado: (2022)

Identifying SARS-CoV-2 infections in South Africa: Balancing public health imperatives with saving lives
por: Baxter, Cheryl, et al.
Publicado: (2021)

Global emergence of SARS-CoV-2 variants: new foresight needed for improved vaccine efficacy
por: Yadav, Pragya D, et al.
Publicado: (2022)

SARS-CoV-2 Lambda and Gamma variants competition in Peru, a country with high seroprevalence
por: Vargas-Herrera, Natalia, et al.
Publicado: (2021)

Offline: It's time to convene nations to end this pandemic
por: Horton, Richard
Publicado: (2020)

COVID-19 will continue but the end of the pandemic is near
por: Murray, Christopher J L
Publicado: (2022)

Assessing the impact of the pandemic in children and adolescents: SARS-CoV-2 infection and beyond
por: Molteni, Erika, et al.
Publicado: (2022)

Respiratory syncytial virus after the SARS-CoV-2 pandemic — what next?
por: Mosscrop, Lucy G., et al.
Publicado: (2022)

Learning from serosurveillance for SARS-CoV-2 to inform pandemic preparedness and response
Publicado: (2023)

Virology, epidemiology, immunology and vaccine development of SARS-CoV-2, update after nine months of pandemic
por: Baay, Marc, et al.
Publicado: (2021)

Monitoring differences between the SARS-CoV-2 B.1.1.7 variant and other lineages
por: Jewell, Britta L
Publicado: (2021)

New year, new SARS-CoV-2 variant: Resolutions on genomic surveillance protocols to face Omicron
por: Oróstica, Karen Y., et al.
Publicado: (2022)

The Social, Economic and Sanitary Impact of COVID-19 Pandemic
por: Gómez, Ana María Autrán, et al.
Publicado: (2020)

Pre-exposure anti-SARS-CoV-2 monoclonal antibodies in severely immunocompromised patients with immune-mediated inflammatory diseases
por: Goulenok, Tiphaine, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dkcp8dvgob1d165tt4md4in275